State Report: New York
Commonwealth Fund State Performance Ranking (2007): 22
Regarding SCHIP, CMS enforced new guidelines and denied New York's request to expand SCHIP coverage to children in families with incomes up to 400% of federal poverty level, which would have provided coverage to an additional 70,000 children. Eligibility currently is set at 250% of poverty level. New York Gov. Eliot Spitzer said the state is preparing a lawsuit to contest the new guidelines.
Most New York City hospitals are in compliance with a new state law that requires them to inform low-income, uninsured patients about financial assistance for medical treatment. Under the law, which took effect in January 2007, hospitals must inform uninsured patients verbally, in writing, or with prominently placed signage, that they could be eligible for state financial aid from an $847 billion charity-care hospital fund. About 40% of New York's 2.2 million uninsured persons are eligible for existing public coverage.
As far as the state's IT push is concerned, Mount Sinai Medical Center and nine other New York City metropolitan-area hospitals have launched a pilot program that provides patients with smart cards which can hold the equivalent of 30 pages of medical records, according to the Philadelphia Inquirer. Forty-five New York and New Jersey hospitals eventually could participate in the program.
MHE Sources: Centers for Medicare & Medicaid Services; Urban Institute; Kaiser Family Foundation; U.S. Census Bureau; The Commonwealth Fund
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Is Journavx a Step Forward In Pain Management or a Repeat of Past Mistakes?
March 25th 2025In a Q&A with Josef Witt-Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares the potential benefits and risks of the alternative non-opioid pain medication, expressing that while it could help cut down on opioid use, its long-term impact is unclear.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
